Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc.

PBH·NYSE

$45.44

-1.1%
HealthcareMedical - Distribution

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

At a Glance

Live Snapshot
Market Cap$2.15B
EPS3.9300
P/E Ratio11.56
Earnings Date08/06/2026

pbh

Investments in Property, Plant, and Equipment

Last Annual Value

-11.18M

3-Year CAGR

-13%

5-Year CAGR

13%

10-Year CAGR

-12%

Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. Competitors Analysis of Investments in Property, Plant, and Equipment

PBH · NYSE
CompanyInvestments in Property, Plant, and Equipment
CAGR 3Y
CAGR 5Y
CAGR 10Y
-11.18M
N/AN/AN/A 
-88.04M
N/AN/AN/A
-67.58M
N/AN/AN/A
-1.20M
N/AN/AN/A
-42.45M
N/AN/AN/A
-933.00K
N/AN/AN/A
0.00
N/AN/AN/A
-58.00K
N/AN/AN/A
-5.03M
N/AN/AN/A
Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. Fair Value Envelope

PBH · NYSE

Our analysis suggests that PBH has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $45.44, this represents a potential HIDDEN relative to our calculated worth for Prestige Consumer Healthcare Inc..

Intrinsic Value
Current Price: $45.44